MedPath

Pulmonary Hypertension Observational Study

Recruiting
Conditions
Pulmonary Hypertension
Interventions
Other: pulmonary hypertension
Registration Number
NCT05958901
Lead Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Brief Summary

The purpose of this study is to establish the large PH cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10000
Inclusion Criteria
  • PH group: When the mean pulmonary artery pressure is greater than 25mmHg at rest or greater than 30mmHg during exercise.
  • Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years.
Exclusion Criteria
  • Acute exacerbation in the past 3 months Having other respiratory diseases with massive lung tissue destruction such as severe bronchiectasis and tuberculosis, etc.
  • Serious uncontrolled diseases thoracic or abdominal surgery in the last 3 months.
  • Eye surgery in the last three months.
  • Retinal detachment myocardial infarction in the last 3 months.
  • Admission to hospital for any cardiac condition in the last month.
  • Heart rate over 120 beats per minute.
  • Antibacterial chemotherapy for tuberculosis pregnant or breast feeding.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
pulmonary hypertensionpulmonary hypertension-
Primary Outcome Measures
NameTimeMethod
mean pulmonary arterial pressure12 months

For an adult at sea level, when the mean pulmonary arterial pressure is greater than 25 mmHg at rest or greater than 30mmHg during exercise.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The First Affiliated Hospital of Guangzhou Medical University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath